Deutsche Bank’s Aratana Therapeutics, Inc. PETX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-34,964
| Closed | -$178K | – | 5562 |
|
|
2019
Q2 | $178K | Sell |
34,964
-195,552
| -85% | -$879K | ﹤0.01% | 3897 |
|
|
2019
Q1 | $829K | Buy |
230,516
+54,329
| +31% | +$235K | ﹤0.01% | 3119 |
|
|
2018
Q4 | $1.08M | Buy |
176,187
+11,840
| +7% | +$72.3K | ﹤0.01% | 2831 |
|
|
2018
Q3 | $960K | Sell |
164,347
-67,848
| -29% | -$339K | ﹤0.01% | 3361 |
|
|
2018
Q2 | $987K | Sell |
232,195
-161,351
| -41% | -$814K | ﹤0.01% | 3435 |
|
|
2018
Q1 | $1.73M | Sell |
393,546
-74,568
| -16% | -$333K | ﹤0.01% | 2960 |
|
|
2017
Q4 | $2.46M | Buy |
468,114
+47,178
| +11% | +$289K | ﹤0.01% | 2581 |
|
|
2017
Q3 | $2.58M | Buy |
420,936
+47,893
| +13% | +$303K | ﹤0.01% | 2374 |
|
|
2017
Q2 | $2.7M | Buy |
373,043
+127,644
| +52% | +$785K | ﹤0.01% | 2363 |
|
|
2017
Q1 | $1.3M | Sell |
245,399
-5,560
| -2% | -$37.5K | ﹤0.01% | 2491 |
|
|
2016
Q4 | $1.8M | Sell |
250,959
-10,967
| -4% | -$88.7K | ﹤0.01% | 2326 |
|
|
2016
Q3 | $2.45M | Sell |
261,926
-36,180
| -12% | -$300K | ﹤0.01% | 2210 |
|
|
2016
Q2 | $1.88M | Buy |
298,106
+70,249
| +31% | +$452K | ﹤0.01% | 2446 |
|
|
2016
Q1 | $1.26M | Sell |
227,857
-58,140
| -20% | -$219K | ﹤0.01% | 2671 |
|
|
2015
Q4 | $1.59M | Buy |
285,997
+62,898
| +28% | +$416K | ﹤0.01% | 2601 |
|
|
2015
Q3 | $1.89M | Buy |
223,099
+36,460
| +20% | +$617K | ﹤0.01% | 2535 |
|
|
2015
Q2 | $2.82M | Buy |
186,639
+164,188
| +731% | +$2.37M | ﹤0.01% | 2191 |
|
|
2015
Q1 | $358K | Sell |
22,451
-21,985
| -49% | -$391K | ﹤0.01% | 3478 |
|
|
2014
Q4 | $790K | Sell |
44,436
-4,721
| -10% | -$58.8K | ﹤0.01% | 3366 |
|
|
2014
Q3 | $492K | Buy |
49,157
+24,408
| +99% | +$296K | ﹤0.01% | 3512 |
|
|
2014
Q2 | $384K | Sell |
24,749
-10,741
| -30% | -$152K | ﹤0.01% | 3677 |
|
|
2014
Q1 | $657K | Buy |
35,490
+26,870
| +312% | +$538K | ﹤0.01% | 3146 |
|
|
2013
Q4 | $163K | Sell |
8,620
-5,548
| -39% | -$113K | ﹤0.01% | 3798 |
|
|
2013
Q3 | $231K | Buy |
14,168
+8,268
| +140% | +$86.9K | ﹤0.01% | 4032 |
|
|
2013
Q2 | $44K | Buy |
+5,900
| New | +$46.7K | ﹤0.01% | 4560 |
|
Other funds holding PETX
Deutsche Bank's PETX Position: Q3 2019 in Review
Deutsche Bank sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 34,964 shares — an estimated $178K sold.
Deutsche Bank first reported a position in PETX in Q2 2013 and held it in 25 quarters. The position peaked at $2.82M in Q2 2015. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.
- Deutsche Bank reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
- Deutsche Bank sold 34,964 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $178K.
- Deutsche Bank first reported a position in Aratana Therapeutics, Inc. in Q2 2013 and held it in 25 quarters.
- Deutsche Bank's Aratana Therapeutics, Inc. position peaked at $2.82M in Q2 2015.
- 2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.
Based on Deutsche Bank's 13F filing for Q3 2019, filed 14 Nov 2019.